Neogen Chemicals Ltd

Neogen Chemicals Ltd's step-down subsidiary, Neogen Morita New Materials Limited (NML), has approved the issuance of 7,20,000 equity shares on a preferential basis. The shares, with a face value of ₹10 each, will be issued at a price of ₹1,066.66 per share, including a premium of ₹1,056.66. The total issue size amounts to ₹76.80 crore. The allottee is Morita Investment Limited (MIL), a wholly-owned subsidiary of Morita Chemicals Industries Co. Limited, in accordance with a Joint Venture Agreement. This issuance was approved by the Board of NML and subsequently by its shareholders at an Extra-Ordinary General Meeting. Post-allotment, Morita Investment Limited will hold a 9.09% stake in NML.

Neogen Chemicals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Insider Trading Policy. The window will be shut from October 1, 2026, until 48 hours after the declaration of the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The specific date for the Board Meeting to approve these results will be communicated later. The company has also uploaded this information on its website.

Neogen Chemicals Ltd. successfully completed its first-ever Qualified Institutions Placement (QIP), raising approximately ₹600 crore. The issue was significantly oversubscribed by more than 6.5 times, attracting strong participation from diverse domestic and global institutional investors, including leading mutual funds and foreign portfolio investors. The company allotted 2,660,753 equity shares at an issue price of ₹2,255 per share, expanding its paid-up equity share capital. The proceeds will be utilized for repayment/pre-payment of certain borrowings, funding long-term working capital requirements, and general corporate purposes. This capital raise aims to reduce indebtedness, improve the debt-to-equity ratio, and provide financial flexibility for future growth opportunities, particularly in advanced battery materials.

Neogen Chemicals Limited announced the successful allotment of 26,60,753 equity shares through a Qualified Institutional Placement (QIP) issue. The shares were issued at ₹2,255 each, a premium to the floor price of ₹2,189.73, raising a total of approximately ₹599.99 crore. This issuance increases the company's paid-up equity share capital to ₹30,04,24,270, comprising 3,00,42,427 equity shares of ₹10 each. The newly allotted shares will be listed on both BSE and NSE and will rank pari passu with existing shares. The QIP was approved by the Board and shareholders, with the Fund-Raising Committee finalizing the allotment on September 16, 2026.

Neogen Chemicals Limited's Fund-Raising Committee has approved the allotment of 26,60,753 equity shares at ₹2,255 per share through a Qualified Institutional Placement (QIP). This issuance, which opened on September 10, 2026, and closed on September 16, 2026, aggregates to ₹5,99,99,98,015. The allotment increases the company's paid-up equity share capital to ₹30,04,24,270, comprising 3,00,42,427 equity shares. The newly allotted shares will be listed on BSE and NSE and will rank pari passu with existing shares.

Neogen Chemicals Ltd has successfully completed a Qualified Institutional Placement (QIP), allotting 26,60,753 equity shares at ₹2,255 per share, aggregating to ₹5,99,99,98,015. The issue price was higher than the floor price of ₹2,189.73. This allotment increases the company's paid-up equity share capital and the equity shares will be listed on BSE and NSE, ranking pari passu with existing shares. The QIP was approved by the Board and shareholders, with the fund-raising committee finalizing the allotment on September 16, 2026.

Neogen Chemicals Ltd has announced the closure of its Qualified Institutions Placement (QIP) issue. The Fund-Raising Committee approved the closure on September 16, 2026, after receiving applications for 26,60,753 equity shares. The issue price has been fixed at ₹2,255 per equity share, including a premium of ₹2,245 per share. The company also approved the placement document and confirmed the allocation note for eligible qualified institutional buyers. The QIP opened on September 10, 2026, and the details are available on the company's website.

Neogen Chemicals Limited's Fund Raising Committee has approved the closure of its Qualified Institutional Placement (QIP) issue. The committee approved the issue price of ₹2,255 per equity share, including a premium of ₹2,245. Applications for 26,60,753 equity shares were received, with funds confirmed in the escrow account. The placement document has been adopted and allocation notes will be sent to eligible QIBs. The QIP opened on September 10, 2026, and this outcome was approved on September 16, 2026, following prior board and shareholder approvals.

Neogen Chemicals Ltd announced the opening of its Qualified Institutions Placement (QIP) issue on September 10, 2026. This follows approvals from the Board of Directors and shareholders. The Fund-Raising Committee approved the preliminary placement document and authorized the opening of the issue. The floor price for the QIP has been set at ₹2,189.73 per equity share, calculated as per SEBI ICDR Regulations. The company may offer a discount of up to 5% on this floor price. The issue price will be finalized in consultation with the lead managers.

Neogen Chemicals Ltd announced the opening of its Qualified Institutions Placement (QIP) issue on September 10, 2026. The Fund-Raising Committee approved the preliminary placement document and authorized the opening of the issue to eligible qualified institutional buyers. The floor price for the QIP has been fixed at ₹2,189.73 per equity share, calculated as per SEBI ICDR Regulations. The company may offer a discount of up to 5% on this floor price. The 'Relevant Date' for the QIP has also been set as September 10, 2026. The issue price will be determined in consultation with the lead managers.